Optimizing the management of HER2-positive early breast cancer: the clinical reality.
暂无分享，去创建一个
J. Mackey | S. Chia | M. Clemons | K. Pritchard | D. Rayson | S. Dent | J. Latreille | L. Provencher | S. Verma | J. Lemieux | B. Wang | S. Verma | S. Lavasani